BCL2 and ovarian carcinoma: The failure to induce apoptosis is one of the underlying causes of drug resistance, and its molecular mechanisms in ovarian cancer cells include abnormal expression of the Bcl-2 family proteins, p53 mutations, upregulation of other inhibitors of apoptosis which block activation of caspases and stabilize the mitochondrial transmembrane potential.